| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 02/22/2006 | EP1627638A1 Fortifier |
| 02/22/2006 | EP1626967A1 Substituted pyrazoles |
| 02/22/2006 | EP1626965A1 Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders |
| 02/22/2006 | EP1626964A2 New benzimidazole derivatives |
| 02/22/2006 | EP1626962A1 Benzamide inhibitors of the p2x7 receptor |
| 02/22/2006 | EP1626957A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 02/22/2006 | EP1441735B1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | EP1237874B1 Selective neurokinin antagonists |
| 02/22/2006 | CN1738814A Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 02/22/2006 | CN1738806A Oxo-azabicyclic compounds |
| 02/22/2006 | CN1738805A N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as CGRP-antagonists for treating a headache |
| 02/22/2006 | CN1738804A 吡唑化合物 Pyrazole compounds |
| 02/22/2006 | CN1738799A Methods for preparing phenylalkyne derivatives |
| 02/22/2006 | CN1738798A Indole derivatives as somatostatin agonists or antagonists |
| 02/22/2006 | CN1243002C Pyrimidinylbenzimidazole and triazinylbenzimidazole derivatives and agricultural/horticultural bactericides |
| 02/22/2006 | CN1242995C Novel compounds, their use and preparation |
| 02/22/2006 | CN1242993C Heterocycle derivatives and drugs |
| 02/22/2006 | CN1242992C Cyclic diamine compounds bearing six-membered cyclic groups |
| 02/21/2006 | US7002021 Diketopyrrolopyrrole pigments |
| 02/21/2006 | US7002019 aryl hydrocarbon; oxidation of 4,5-dihydro-1,3-azoles to fully unsaturated ring; heterocyclic ketones |
| 02/21/2006 | US7002013 Pt complexes as phosphorescent emitters in the fabrication of organic light emitting diodes |
| 02/21/2006 | US7001917 2-(4-(4-(4-Fluorophenyl)-3,5-imethyl-1H-pyrazol-1-yl)phenyl) ethyl (4-methylphenyl)sulfonylcarbamate ammonium salt, e.g., as an antagonist for Prostoglandin E receptor; analgesics; antipyretics; antiinflammatory agents |
| 02/21/2006 | US7001904 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases |
| 02/21/2006 | US7001901 Tetrazolylpropionamides as inhibitors of Aβ protein production |
| 02/21/2006 | US7001898 Treating conditions involving increased vascular resistance and cardiac insufficiency. |
| 02/21/2006 | CA2395196C Cyclic amp-specific phosphodiesterase inhibitors |
| 02/21/2006 | CA2250347C Piperazine and piperidine compounds with high affinity for dopamine-d2 and serotonin-5ht1a receptors |
| 02/21/2006 | CA2186224C Amidino derivatives useful as nitric oxide synthase inhibitors |
| 02/16/2006 | WO2006017055A2 Pyrazole amide derivatives, compositions containing such compounds and methods of use |
| 02/16/2006 | WO2006016278A1 Novel quinoxalinone norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| 02/16/2006 | WO2006015986A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 02/16/2006 | WO2006015854A2 Azetidine derivatives as ccr-3 receptor antagonists |
| 02/16/2006 | WO2005118544A3 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
| 02/16/2006 | WO2005097137A3 Advanced quinazoline based protein kinase inhibitors |
| 02/16/2006 | US20060036101 Substituted indole compounds, their preparation and use in medicaments |
| 02/16/2006 | US20060036098 Carbonylamino-benzimidazole derivatives as androgen receptor modulators |
| 02/16/2006 | US20060035951 anticancer, antitumor agents; 1-(3-fluorophenyl)-N-[3(5)-phenylpyrazol-5(3)-yl]-1H-benzimidazole-5-carboxamide; SCF-induced tyrosine phosphorylation of Kit in intact H526 cells; inhibit the tyrosine kinase activity of c-Kit |
| 02/16/2006 | US20060035945 Prevent reproduction, infection of virus; antitumor agents |
| 02/16/2006 | US20060035935 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/16/2006 | US20060035934 Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor |
| 02/16/2006 | US20060035916 2,4-Pyrimidinediamine compounds and their uses |
| 02/16/2006 | US20060035906 Converting hydroxyl group in 1-formyl-4-(2-hydroxyethyl) piperazine to a leaving group, reacting with 2-mercaptobenzimidazole , and removing the formyl group; formyl derivative is prepared by formylating 1-(2-hydroxyethyl)piperazine |
| 02/16/2006 | US20060035896 Inhibitors of lysophosphatidic acid acyltransferase beta (LPAAT- beta ) activity; cancer screening and therapy |
| 02/16/2006 | US20060035891 (1S, 2R)-N4-(2-Aminocarbonylcyclopent-1-yl)-5-fluoro-N2-[4-(4-methylpiperazin-1-yl)-3-methylphenyl]-2,4-pyrimidinediamine, having antiproliferative activity, used to inhibit cellular proliferation and to treat proliferate diseases such as cancers |
| 02/16/2006 | CA2576581A1 Substituted indole compounds, their preparation and use in medicaments |
| 02/16/2006 | CA2576258A1 Novel quinoxalinone norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| 02/16/2006 | CA2574827A1 4-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 02/16/2006 | CA2573066A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 02/16/2006 | CA2572748A1 Organic compounds |
| 02/16/2006 | CA2572745A1 Pyrazole amide derivatives, compositions containing such compounds and methods of use |
| 02/15/2006 | EP1626043A1 Heterocyclic thioesters |
| 02/15/2006 | EP1625125A1 Compounds as crf1 receptor antagonists |
| 02/15/2006 | EP1625121A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 02/15/2006 | EP1625119A1 Substituted-1-phthalazinamines as vr-1 antagonists |
| 02/15/2006 | CN1735609A Diazepanes derivatives useful as LFA inhibitors |
| 02/15/2006 | CN1735607A 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer |
| 02/15/2006 | CN1735605A Phenylalanine derivatives as depeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/15/2006 | CN1735595A Substituted alkyl amido piperidines |
| 02/15/2006 | CN1735592A Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 02/15/2006 | CN1733758A Imide analog compounds and its preparation method |
| 02/15/2006 | CN1733735A N-2-pyrimidinyl oxy-benzyl substituted cyclic amine compound, its preparation process and uses |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1733723A Indole and dihydroindole derivatives |
| 02/15/2006 | CN1241916C Novel acardite compound, its preparation method and medicinal composition containing said compound |
| 02/14/2006 | US6998416 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/14/2006 | US6998414 Substituted arylamides as IP antagonists |
| 02/14/2006 | US6998413 Anticarcinogenica agents, antitumor agents; a new pyrrolo[1,2-a]benzimidazole derivatives from existing drug; cytotoxic; central nervous system, ovarian, and lung cancers; potentiation |
| 02/14/2006 | US6998403 Antidepressants; N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-1,2-dihydro-3H-benzo[e]indole-3-carboxamide; antagonist of adrenergic receptor, serotonin receptor; anxiety, schizophrenia, Parkinson's disease, cognitive disorders, schizophrenia |
| 02/14/2006 | US6998272 used as scaffolds in the combinatorial synthesis of receptor molecules; solid phase synthesis |
| 02/14/2006 | CA2247889C Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 02/14/2006 | CA2241186C Benzimidazole derivatives |
| 02/14/2006 | CA2218945C 4-aminoquinazoline derivatives |
| 02/14/2006 | CA2105666C New centrally acting substituted phenylazacycloalkanes |
| 02/09/2006 | WO2006014877A2 Potassium channel inhibitors |
| 02/09/2006 | WO2006014665A2 Arylpyrrolidine derivatives as nk-1/ssri antagonists |
| 02/09/2006 | WO2006014482A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 02/09/2006 | WO2006014290A2 Anti-inflammatory medicaments |
| 02/09/2006 | WO2006014005A1 Pyrazole derivative |
| 02/09/2006 | WO2006013049A2 Benzyloxy derivatives as maob inhibitors |
| 02/09/2006 | WO2005118558A3 Pyrimidine compounds and use thereof |
| 02/09/2006 | WO2005108392A3 Process for preparing ondansetron hydrochloride dihydrate having a defined particle size |
| 02/09/2006 | WO2003090691A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 02/09/2006 | US20060030717 5-(2-Cyano-5-pyrolyl)-2-indolinones: 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'yl)-1-methyl-1H-pyrrole-2-carbonitrile; contraceptives, hormone replacement therapy, dysmenorrhea, premenstrual syndrome, hormone-dependent neoplasia, uterine bleeding |
| 02/09/2006 | US20060030712 Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof |
| 02/09/2006 | US20060030707 Fluorescent whitening agent, for whitening synthetic or natural organic materials, especially paper and for the fluorescent whitening and improvement of sun protection factors of textile materials |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030613 Indole, indazole and indoline derivatives as CETP inhibitors |
| 02/09/2006 | US20060030595 Potassium channel inhibitors |
| 02/09/2006 | US20060030593 1-Heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/09/2006 | US20060030592 I-Oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels |
| 02/09/2006 | US20060030591 Crystalline polymorph of pipindoxifene hydrochloride monohydrate |
| 02/09/2006 | US20060030590 such as 2-Ethyl-5-fluoro-1-{1-[3-(4-fluorophenylsulfanyl)-propyl]-piperidin-4-yl}-1H-benzimidazole, used as modulators of chemokine receptor activity, for treatment and prevention of inflammatory diseases such as asthma, allergies and autoimmune diseases, such as rheumatoid arthritis and atherosclerosis |
| 02/09/2006 | US20060030588 Heteroaryl urea neuropeptide Y Y5 receptor antagonists |
| 02/09/2006 | US20060030576 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| 02/09/2006 | US20060030573 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes |
| 02/09/2006 | US20060030568 Crystal modificaion of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use |
| 02/09/2006 | US20060030566 Novel quinoxalinone norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| 02/09/2006 | US20060030563 novel cannabimimetic pyrazole derivatives, that are less lipophilic and have shorter in vivo half-lives than known cannabimimetic pyrazole ligands, used to provide physiological effects for treating diseases, such as drug abuse, obesity, schizophrenia, epilepsy or cognition activators |
| 02/09/2006 | US20060030560 Pyrimidine compounds |